Condition
Myelodysplastic Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Myelodysplastic Neoplasm clinical trials that are recruiting, at sites in 4 countries (most in Hong Kong (1), Czechia (1), China (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Myelodysplastic Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Proton total marrow irradiation before allogeneic transplant for high-risk AML or MDS | Phase 1/2 | Prague and 1 other locations | Recruiting | Apr 16, 2026 |
| Oral arsenic trioxide plus vitamin C with low-intensity therapy for TP53-mutated AML/MDS/CMML | Phase 2 | Hong Kong | Recruiting | Jan 16, 2025 |
| Intensive conditioning for myeloid cancers with extramedullary involvement | — | Shanghai, Shanghai Municipality | Recruiting | Nov 1, 2023 |
| Using Metformin to Prevent Leukemia in Patients with Preleukemia and Low-Risk MDS | Phase 2 | Copenhagen, Copenhagen N | Recruiting | Feb 5, 2021 |
All recruiting trials (4)
-
Proton total marrow irradiation before allogeneic transplant for high-risk AML or MDS
This trial tests whether adding proton-based total marrow irradiation to standard chemotherapy conditioning before allogeneic stem cell transplant can improve outcomes for adults with high-risk or relapsed/refractory AML or MDS.
-
Oral arsenic trioxide plus vitamin C with low-intensity therapy for TP53-mutated AML/MDS/CMML
This trial will test whether taking oral arsenic trioxide with vitamin C plus a low-intensity drug (a hypomethylating agent, with or without venetoclax) helps adults with TP53-mutated AML, MDS, or CMML who are newly diagnosed or have relapsed/refractory disease.
-
Intensive conditioning for myeloid cancers with extramedullary involvement
This study is testing a new treatment plan using specific medications before a stem cell transplant to see if it helps people with myeloid cancers that have spread beyond the bone marrow feel better and have better outcomes.
-
Using Metformin to Prevent Leukemia in Patients with Preleukemia and Low-Risk MDS
This study is testing if the diabetes drug metformin can help prevent leukemia in people with preleukemia or low-risk blood disorders.
Related topics
Quick answers
How many Myelodysplastic Neoplasm clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Hong Kong (1 trial), Czechia (1 trial), China (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.